Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 07, 2005. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The material change disclosed is a transaction by Mr. J Heslop on October 06, 2005, involving the purchase of Ordinary Shares under a Single Company ISA at a price of GBP14.45 per share. The filing does not detail material changes to the company's financial position or operations.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly adheres to Disclosure Rule 3.1.4R(1)(b) regarding the notification of the share purchase.
Key Facts for Investor Verification
- Transaction Date: October 06, 2005
- Person Involved: Mr. J Heslop
- Transaction Type: Purchase of Ordinary Shares via Single Company ISA
- Share Price: GBP14.45 per Ordinary Share
- Notification Date: October 07, 2005